Početna stranicaSDZ • SWX
add
Sandoz Group AG
Preth. zaklj. cijena
33,06 CHF
Dnevni raspon
31,94 CHF - 32,53 CHF
Godišnji raspon
26,25 CHF - 45,10 CHF
Tržišna kapitalizacija
14,13 mlr. CHF
Prosječna količina
1,57 mil.
P/E omjer
-
Prinos dividende
1,84 %
Glavno tržište vrijednosnica
SWX
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (USD) | pro 2024.info | Godišnja promjena |
|---|---|---|
Prihod | 2,66 mlr. | 5,41 % |
Operativni troškovi | 1,29 mlr. | 12,91 % |
Neto dohodak | −75,00 mil. | 5,06 % |
Neto profitabilnost | −2,82 | 9,90 % |
Zarada po dionici | — | — |
EBITDA | 96,50 mil. | 91,09 % |
Efektivna porezna stopa | 30,23 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (USD) | pro 2024.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 1,19 mlr. | 7,39 % |
Ukupna imovina | 19,91 mlr. | 2,45 % |
Ukupne obveze | 11,74 mlr. | 8,97 % |
Ukupni kapital | 8,16 mlr. | — |
Dionice u optjecaju | 430,70 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 1,74 | — |
Povrat imovine | −0,16 % | — |
Povrat kapitala | −0,24 % | — |
Tok novca
Neto promjena novca
| (USD) | pro 2024.info | Godišnja promjena |
|---|---|---|
Neto dohodak | −75,00 mil. | 5,06 % |
Gotovina od poslovanja | 213,50 mil. | 54,15 % |
Gotovina iz ulaganja | −173,00 mil. | 18,97 % |
Gotovina iz financiranja | 235,00 mil. | −56,48 % |
Neto promjena novca | 245,00 mil. | −50,10 % |
Slobodan tok novca | −85,38 mil. | 38,74 % |
Više
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland. Sandoz is one of the leading global generics businesses. Wikipedia
Glavni izvršni direktor
Osnovano
1886
Web-lokacija
Zaposlenici
22.049
